Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Champions Oncology (CSBR) Cost of Revenue (2016 - 2026)

Champions Oncology has reported Cost of Revenue over the past 17 years, most recently at $2.7 million for Q1 2026.

  • For Q1 2026, Cost of Revenue fell 59.71% year-over-year to $2.7 million; the TTM value through Jan 2026 reached $19.1 million, up 215.99%, while the annual FY2025 figure was $28.4 million, 301.88% up from the prior year.
  • Cost of Revenue for Q1 2026 was $2.7 million at Champions Oncology, down from $7.3 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $18.9 million in Q2 2022 and troughed at -$15.1 million in Q2 2024.
  • A 5-year average of $5.0 million and a median of $7.1 million in 2022 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: soared 1181.79% in 2022 and later tumbled 305.6% in 2024.
  • Year by year, Cost of Revenue stood at $7.4 million in 2022, then decreased by 11.08% to $6.6 million in 2023, then grew by 12.24% to $7.4 million in 2024, then decreased by 2.23% to $7.3 million in 2025, then plummeted by 63.29% to $2.7 million in 2026.
  • Business Quant data shows Cost of Revenue for CSBR at $2.7 million in Q1 2026, $7.3 million in Q4 2025, and $1.9 million in Q3 2025.